📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Valera Pharmaceuticals

1.1 - Company Overview

Valera Pharmaceuticals Logo

Valera Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical services concentrating on development.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Valera Pharmaceuticals

Cephalon Logo

Cephalon

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery, development, and commercialization of medications to improve quality of life worldwide. Founded in 1987, the company delivers first-in-class and best-in-class medicines across several therapeutic areas.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cephalon company profile →
Arrowhead Pharmaceuticals Logo

Arrowhead Pharmaceuticals

HQ: United States Website
  • Description: Provider of RNAi therapeutics for genetically driven diseases with protein overproduction, leveraging the TRiM platform for ligand-mediated, tissue-specific delivery. Pipeline includes plozasiran (ARO-APOC3) for hypertriglyceridemia, zodasiran (ARO-ANG3) for mixed dyslipidemia, and ARO programs targeting RAGE, MUC5AC, and MMP7 for inflammatory and muco-obstructive lung diseases and idiopathic pulmonary fibrosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arrowhead Pharmaceuticals company profile →
Covagen Logo

Covagen

HQ: Switzerland Website
  • Description: Provider of bispecific FynomAbs by fusing human Fynomer binding proteins to antibodies, creating protein-based therapeutics with novel modes of action and enhanced efficacy for the treatment of inflammatory diseases and cancer; ability to fuse Fynomers to multiple antibody sites enables tailored architectures.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Covagen company profile →
PD-Rx Pharmaceuticals Logo

PD-Rx Pharmaceuticals

HQ: United States Website
  • Description: Provider of quality products and personal customer service to the healthcare industry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PD-Rx Pharmaceuticals company profile →
Unigene Laboratories Logo

Unigene Laboratories

HQ: United States Website
  • Description: Provider of biopharmaceutical peptide drug research, development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Unigene Laboratories company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Valera Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Valera Pharmaceuticals

2.2 - Growth funds investing in similar companies to Valera Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Valera Pharmaceuticals

4.2 - Public trading comparable groups for Valera Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Valera Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Valera Pharmaceuticals

What does Valera Pharmaceuticals do?

Valera Pharmaceuticals is a provider of specialty pharmaceutical services concentrating on development.

Who are Valera Pharmaceuticals's competitors?

Valera Pharmaceuticals's competitors and similar companies include Cephalon, Arrowhead Pharmaceuticals, Covagen, PD-Rx Pharmaceuticals, and Unigene Laboratories.

Where is Valera Pharmaceuticals headquartered?

Valera Pharmaceuticals is headquartered in United States.

How many employees does Valera Pharmaceuticals have?

Valera Pharmaceuticals has 1,000 employees 🔒.

When was Valera Pharmaceuticals founded?

Valera Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Valera Pharmaceuticals in?

Valera Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Valera Pharmaceuticals

Who are the top strategic acquirers in Valera Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Valera Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Valera Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Valera Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Valera Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Valera Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Valera Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Valera Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Valera Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Valera Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Valera Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Valera Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Valera Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Valera Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Valera Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Valera Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Valera Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Valera Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Valera Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Valera Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Valera Pharmaceuticals